Vincerx Pharma (VINC) Proxy Filing summary

Executive summary

• Special Meeting of Stockholders scheduled for June 18, 2025, to consider approval of liquidation and dissolution under Delaware law.

• Board recommends voting in favor of the Dissolution Proposal to expedite the process and maximize potential distributions.

• Delays in approval may increase expenses and reduce the likelihood of distributions to stockholders.

Voting matters and shareholder proposals

• Primary proposal is the approval of the liquidation and dissolution of the company.

• Board unanimously recommends a FOR vote on the Dissolution Proposal.

• Voting can be done online, by mail, by phone, or electronically at the meeting.

Executive compensation and say-on-pay

• Acting Chief Executive Officer Raquel E. Izumi signed the communication to stockholders.